Investors have circled back to healthcare stocks this year, and they’re likely to stick around. If they came for the ...

Illumina Inc. closed $13.90 short of its 52-week high ($144.02), which the company achieved on January 31st.

On Thursday, Illumina Inc (ILMN) stock saw a modest uptick, ending the day at $132.27 which represents a slight increase of $6.12 or 4.85% from the prior close of $126.15. The stock opened at $128.04 ...

Check the time stamp on this data. Updated AI-Generated Signals for Illumina Inc. (ILMN) available here: ILMN.

Leerink Partners analyst Puneet Souda reiterated a Buy rating on Quanterix (QTRX – Research Report) today. The company’s shares ...

The stock's rise snapped a four-day losing streak.

ESMO 2024, which followed hot on the heels of this year’s World Conference on Lung Cancer, was abuzz with data around PD-1 ...

The Rome Study demonstrated the value of extensive sequencing and discussion of individual cancer cases to offer tailored therapeutic choices.

Investors have poured billions of dollars into the "liquid biopsy" space for the early detection and tracking of cancer. Now ...

As the Distinguished William S. C. Chang Endowed Chair in the UC San Diego Jacobs School of Engineering’s Department of ...

Illumina Inc (ILMN) stock saw a decline, ending the day at $128.82 which represents a decrease of $-1.28 or -0.98% from the prior close of $130.1. The stock opened at $130.49 and touched a low of $128 ...

US stocks rose on Tuesday, helping the Dow and S&P 500 both to set new record highs, with sentiment continuing to be lifted ...